At the protein level, PSMD3 was found to be upregulated in 5/5 (100%) CPTAC cancers, including breast cancer, colon cancer, ovarian cancer, clear cell RCC, and UCEC (Figure 2B). Here, PSMD3 is linked to breast cancer.